KISQALI FEMARA CO-PACK prescription and dosage information for physicians and health care professionals. Pharmacology, adverse reactions, warnings, and KISQALI FEMARA CO-PACKside effects.

Femara is not a wonder drug. There is no proof yet that it helps patients live any longer than tamoxifen does. But an international study of 907 postmenopausal women with advanced breast cancer ...

Lannett Company announced it has received approval from the Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Letrozole Tablets, the generic version of Novartis ...

New research backs up earlier reports that the breast cancer drug Femara can reduce the risk of breast cancer recurrence by nearly 50 percent in women previously treated with tamoxifen.

LONDON (MarketWatch) -- Swiss pharmaceutical giant Novartis AG NVS, +0.74% zz:001200526 on Monday said the U.S. Food and Drug Administration has granted its Femara drug priority review for a new ...